Trevi Therapeutics (TRVI)
(Real Time Quote from BATS)
$2.93 USD
+0.20 (7.33%)
Updated May 14, 2024 03:50 PM ET
After-Market: $2.91 -0.02 (-0.68%) 4:06 PM ET
3-Hold of 5 3
D Value F Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/08/2024
Time: -- |
6/2024 | $-0.11 | -4.76% |
Earnings Summary
For their last quarter, Trevi Therapeutics (TRVI) reported earnings of -$0.11 per share, missing the Zacks Consensus Estimate of -$0.09 per share. This reflects a negative earnings surprise of 22.22%. Look out for TRVI's next earnings release expected on August 08, 2024. For the next earning release, we expect the company to report earnings of -$0.11 per share, reflecting a year-over-year decrease of 57.14%.
Earnings History
Price & Consensus
Zacks News for TRVI
Why Trevi Therapeutics (TRVI) Stock Might be a Great Pick
TRVI: What are Zacks experts saying now?
Zacks Private Portfolio Services